ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 2 Recall

Class 2 Recall on Ranitidine Tablets 150mg & 300mg

Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
7056195RANITIDINE TAB 150MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069087RANITIDINE TAB 150MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
7056203RANITIDINE TAB 300MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069046RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1179191RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE

For stock control enquiries please contact Medreich Plc Customer Service team on 020 8831 1580 or cs_team@medreich.co.uk

For medical information enquiries please contact Medreich Plc Pharmacovigilance Department on 020 8831 1580 or info@medreich.co.uk .

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.